Tag: DGCI

News: India’s first COVID-19 vaccine candidate COVAXIN has received the approval of Drug Controller General of India(DCGI) for phase I and II of human clinical trials. Facts: COVAXIN: It is an inactivated vaccine created from a strain of the infectious SARS-CoV-2 virus. Developed by: It has been developed by Bharat Biotech in collaboration with the… Continue reading India’s first COVID-19 vaccine candidate COVAXIN gets DCGI approval